(CIDRAP News) Just days before a Council of Europe hearing to discuss claims that pharmaceutical companies influenced the World Health Organization's (WHO's) pandemic response, the global body said charges by some European officials that the pandemic is "fake" are "wrong and irresponsible."
(CIDRAP News) A multi-national team of researchers has applied a new genomic tool to a 50-year-old bacterial foe, using minute mutations to track the spread of drug-resistant staph both across continents and within a single hospital.
(CIDRAP News) The H1N1 influenza pandemic brought no "devastating surprises," but what has surprised public health agencies is the public's lack of interest in getting vaccinated, Margaret Chan, director-general of the World Health Organization (WHO), said yesterday.
(CIDRAP News) During a week federal officials set aside to push flu immunization, a new report today reveals that pandemic vaccine uptake is low in two of the top priority groupsthose with chronic conditions and healthcare workers.
The report outlining the challenges public health officials face in vaccinating target groups came as federal officials released their latest estimates of pandemic flu cases, hospitalizations, and deaths.
(CIDRAP News) – The World Health Organization (WHO) and vaccine makers from Europe today defended themselves against the charges of some European officials that the agency was improperly influenced by vaccine companies and exaggerated the threat of the pandemic H1N1 virus.
(CIDRAP News) Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.
(CIDRAP News) Federal officials and representatives from some of the nation's biggest health advocacy groups today teamed up to push the importance of pandemic H1N1 vaccination for people who have chronic medical conditions such as asthma, diabetes, and cancer.
(CIDRAP News) The US government recently cut back its contract for H1N1 influenza vaccine from Australian-based CSL Biotherapies by about 60%, mainly as a result of delays related to the company's commitment to make vaccine for Australia first.
(CIDRAP News) Warning against complacency about H1N1 influenza, Dr. Anne Schuchat of the Centers for Disease Control and Prevention (CDC) said she doesn't want to see a repeat of what happened in 1957-58, when a perception that the pandemic was over was followed by a winter surge of flu- and pneumonia-related deaths.
